1 Min Read
June 8 (Reuters) - Valeant Pharmaceuticals International Inc :
* Valeant CEO Papa says it is not his goal to get the company's debt down to zero
* Valeant CEO Papa says the "right place" for the company's debt is "somewhere in the range of $15 billion - $20 billion"
* Valeant CEO Papa says he expects Dendreon sale to close mid-2017 Further company coverage: